Annual CFO
-$217.00 K
+$17.22 M+98.76%
May 26, 2024
Summary
- As of March 13, 2025, LFCR annual cash flow from operations is -$217.00 thousand, with the most recent change of +$17.22 million (+98.76%) on May 26, 2024.
- During the last 3 years, LFCR annual CFO has fallen by -$16.69 million (-101.32%).
- LFCR annual CFO is now -100.73% below its all-time high of $29.84 million, reached on May 1, 2017.
Performance
LFCR Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$6.11 M
-$5.47 M-850.23%
November 24, 2024
Summary
- As of March 13, 2025, LFCR quarterly cash flow from operations is -$6.11 million, with the most recent change of -$5.47 million (-850.23%) on November 24, 2024.
- Over the past year, LFCR quarterly CFO has stayed the same.
- LFCR quarterly CFO is now -133.45% below its all-time high of $18.27 million, reached on February 1, 2006.
Performance
LFCR Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
$71.00 K
-$7.40 M-99.05%
November 24, 2024
Summary
- As of March 13, 2025, LFCR TTM cash flow from operations is $71.00 thousand, with the most recent change of -$7.40 million (-99.05%) on November 24, 2024.
- Over the past year, LFCR TTM CFO has stayed the same.
- LFCR TTM CFO is now -99.81% below its all-time high of $37.51 million, reached on February 1, 2017.
Performance
LFCR TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
LFCR Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +98.8% | 0.0% | 0.0% |
| 3 y3 years | -101.3% | 0.0% | 0.0% |
| 5 y5 years | -101.3% | 0.0% | 0.0% |
LFCR Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -101.3% | +99.0% | -170.7% | +65.6% | -99.0% | +100.3% |
| 5 y | 5-year | -101.3% | +99.0% | -135.9% | +65.6% | -99.6% | +100.3% |
| alltime | all time | -100.7% | +99.0% | -133.4% | +65.6% | -99.8% | +100.3% |
Lifecore Biomedical Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Nov 2024 | - | -$6.11 M(+850.2%) | $71.00 K(-99.0%) |
| Aug 2024 | - | -$643.00 K(-107.4%) | $7.47 M(-3541.9%) |
| May 2024 | -$217.00 K(-98.8%) | $8.64 M(-575.8%) | -$217.00 K(-98.0%) |
| Feb 2024 | - | -$1.82 M(-241.0%) | -$11.12 M(-47.1%) |
| Nov 2023 | - | $1.29 M(-115.5%) | -$21.03 M(-14.8%) |
| Aug 2023 | - | -$8.33 M(+268.2%) | -$24.67 M(+41.4%) |
| May 2023 | -$17.44 M(-22.8%) | -$2.26 M(-80.7%) | -$17.44 M(+10.9%) |
| Feb 2023 | - | -$11.72 M(+398.3%) | -$15.73 M(-27.7%) |
| Nov 2022 | - | -$2.35 M(+113.7%) | -$21.74 M(-11.4%) |
| Aug 2022 | - | -$1.10 M(+100.9%) | -$24.52 M(+8.6%) |
| May 2022 | -$22.59 M(-237.2%) | -$548.00 K(-96.9%) | -$22.59 M(+39.7%) |
| Feb 2022 | - | -$17.74 M(+245.3%) | -$16.17 M(+157.1%) |
| Nov 2021 | - | -$5.14 M(-718.2%) | -$6.29 M(-2338.8%) |
| Aug 2021 | - | $831.00 K(-85.8%) | $281.00 K(-98.3%) |
| May 2021 | $16.47 M(-196.7%) | - | - |
| May 2021 | - | $5.87 M(-174.7%) | $16.47 M(-883.2%) |
| Feb 2021 | - | -$7.86 M(-647.5%) | -$2.10 M(-112.9%) |
| Nov 2020 | - | $1.44 M(-91.6%) | $16.34 M(+201.5%) |
| Aug 2020 | - | $17.02 M(-234.0%) | $5.42 M(-131.8%) |
| May 2020 | -$17.04 M(-206.4%) | -$12.70 M(-220.0%) | -$17.04 M(+195.5%) |
| Feb 2020 | - | $10.58 M(-211.6%) | -$5.77 M(+55.7%) |
| Nov 2019 | - | -$9.48 M(+74.4%) | -$3.71 M(-144.1%) |
| Aug 2019 | - | -$5.44 M(+280.6%) | $8.39 M(-47.6%) |
| May 2019 | $16.02 M(-19.0%) | -$1.43 M(-111.3%) | $16.02 M(-5.4%) |
| Feb 2019 | - | $12.65 M(+383.2%) | $16.93 M(-7.2%) |
| Nov 2018 | - | $2.62 M(+19.7%) | $18.25 M(-1.5%) |
| Aug 2018 | - | $2.19 M(-519.6%) | $18.52 M(-6.4%) |
| May 2018 | $19.78 M(-33.7%) | -$521.00 K(-103.7%) | $19.78 M(-26.6%) |
| Feb 2018 | - | $13.96 M(+383.9%) | $26.96 M(-12.0%) |
| Nov 2017 | - | $2.89 M(-16.3%) | $30.65 M(+14.3%) |
| Aug 2017 | - | $3.45 M(-48.2%) | $26.82 M(-10.1%) |
| May 2017 | $29.84 M(+43.7%) | $6.66 M(-62.3%) | $29.84 M(-20.5%) |
| Feb 2017 | - | $17.65 M(-1978.1%) | $37.51 M(+56.3%) |
| Nov 2016 | - | -$940.00 K(-114.5%) | $24.01 M(-17.2%) |
| Aug 2016 | - | $6.47 M(-54.9%) | $28.99 M(+39.6%) |
| May 2016 | $20.76 M(-22.0%) | $14.33 M(+245.5%) | $20.76 M(+5.5%) |
| Feb 2016 | - | $4.15 M(+2.5%) | $19.67 M(-23.0%) |
| Nov 2015 | - | $4.05 M(-329.3%) | $25.55 M(+22.2%) |
| Aug 2015 | - | -$1.76 M(-113.3%) | $20.91 M(-21.4%) |
| May 2015 | $26.62 M(+26.5%) | $13.24 M(+32.1%) | $26.62 M(+29.3%) |
| Feb 2015 | - | $10.03 M(-1790.7%) | $20.59 M(+2.4%) |
| Nov 2014 | - | -$593.00 K(-115.0%) | $20.10 M(-1.7%) |
| Aug 2014 | - | $3.94 M(-45.3%) | $20.45 M(-2.8%) |
| May 2014 | $21.05 M(-0.9%) | $7.21 M(-24.4%) | $21.05 M(-2.5%) |
| Feb 2014 | - | $9.54 M(-3994.3%) | $21.59 M(-6.7%) |
| Nov 2013 | - | -$245.00 K(-105.4%) | $23.14 M(+11.9%) |
| Aug 2013 | - | $4.54 M(-41.5%) | $20.68 M(-2.6%) |
| May 2013 | $21.23 M(-4.3%) | $7.75 M(-30.1%) | $21.23 M(-21.7%) |
| Feb 2013 | - | $11.09 M(-510.6%) | $27.12 M(+7.2%) |
| Nov 2012 | - | -$2.70 M(-153.1%) | $25.31 M(+10.5%) |
| Aug 2012 | - | $5.08 M(-62.7%) | $22.91 M(+3.3%) |
| May 2012 | $22.18 M(+53.3%) | $13.65 M(+47.1%) | $22.18 M(+109.8%) |
| Feb 2012 | - | $9.28 M(-281.9%) | $10.57 M(-9.3%) |
| Nov 2011 | - | -$5.10 M(-217.0%) | $11.66 M(-19.3%) |
| Aug 2011 | - | $4.36 M(+114.2%) | $14.44 M(-0.2%) |
| May 2011 | $14.47 M | $2.04 M(-80.4%) | $14.47 M(+12.7%) |
| Feb 2011 | - | $10.37 M(-547.8%) | $12.84 M(+140.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Nov 2010 | - | -$2.31 M(-152.8%) | $5.34 M(-29.6%) |
| Aug 2010 | - | $4.38 M(+987.6%) | $7.59 M(+1.4%) |
| May 2010 | $7.48 M(-20.7%) | $403.00 K(-86.0%) | $7.48 M(-26.7%) |
| Feb 2010 | - | $2.87 M(-4323.5%) | $10.20 M(-1.7%) |
| Nov 2009 | - | -$68.00 K(-101.6%) | $10.38 M(-10.2%) |
| Aug 2009 | - | $4.28 M(+36.9%) | $11.56 M(+22.5%) |
| May 2009 | $9.44 M(-46.1%) | $3.12 M(+2.4%) | $9.44 M(-23.8%) |
| Feb 2009 | - | $3.05 M(+175.4%) | $12.38 M(-22.6%) |
| Nov 2008 | - | $1.11 M(-48.5%) | $16.01 M(+3.2%) |
| Aug 2008 | - | $2.15 M(-64.6%) | $15.52 M(-11.4%) |
| May 2008 | $17.52 M(-949.7%) | $6.07 M(-9.1%) | $17.52 M(+5.7%) |
| Feb 2008 | - | $6.68 M(+982.0%) | $16.57 M(+71.4%) |
| Nov 2007 | - | $617.00 K(-85.2%) | $9.67 M(+140.4%) |
| Aug 2007 | - | $4.16 M(-18.8%) | $4.02 M(-295.0%) |
| May 2007 | -$2.06 M(-119.0%) | $5.12 M(-2346.1%) | -$2.06 M(-54.9%) |
| Feb 2007 | - | -$228.00 K(-95.5%) | -$4.57 M(-132.8%) |
| Nov 2006 | - | -$5.03 M(+161.1%) | $13.92 M(+24.5%) |
| Aug 2006 | - | -$1.93 M(-173.8%) | $11.18 M(+2.9%) |
| May 2006 | $10.87 M(-16.7%) | $2.61 M(-85.7%) | $10.87 M(+17.8%) |
| Feb 2006 | - | $18.27 M(-335.1%) | $9.22 M(+98.0%) |
| Nov 2005 | - | -$7.77 M(+246.7%) | $4.66 M(-59.6%) |
| Aug 2005 | - | -$2.24 M(-331.0%) | $11.52 M(-11.7%) |
| May 2005 | $13.05 M(+73.7%) | $970.00 K(-92.9%) | $13.05 M(+1.1%) |
| Feb 2005 | - | $13.70 M(-1607.2%) | $12.91 M(+20.3%) |
| Nov 2004 | - | -$909.00 K(+27.5%) | $10.73 M(+95.3%) |
| Aug 2004 | - | -$713.00 K(-185.5%) | $5.50 M(-26.8%) |
| May 2004 | $7.51 M(+251.1%) | $834.00 K(-92.8%) | $7.51 M(+6.5%) |
| Feb 2004 | - | $11.52 M(-287.4%) | $7.05 M(-303.5%) |
| Nov 2003 | - | -$6.15 M(-571.8%) | -$3.46 M(+396.4%) |
| Aug 2003 | - | $1.30 M(+246.5%) | -$698.00 K(-82.9%) |
| May 2003 | $2.14 M(-2217.8%) | - | - |
| Apr 2003 | - | $376.00 K(-62.5%) | -$4.08 M(-47.0%) |
| Jan 2003 | - | $1.00 M(-129.7%) | -$7.69 M(+7516.8%) |
| Oct 2002 | -$101.00 K(-98.7%) | -$3.38 M(+62.6%) | -$101.00 K(-103.0%) |
| Jul 2002 | - | -$2.08 M(-35.8%) | $3.40 M(-10.0%) |
| Apr 2002 | - | -$3.24 M(-137.7%) | $3.78 M(-38.9%) |
| Jan 2002 | - | $8.60 M(+6776.0%) | $6.19 M(-181.8%) |
| Oct 2001 | -$7.57 M(-275.8%) | $125.00 K(-107.3%) | -$7.57 M(+46.4%) |
| Jul 2001 | - | -$1.70 M(+105.4%) | -$5.17 M(+126.7%) |
| Apr 2001 | - | -$828.00 K(-84.0%) | -$2.28 M(+5.7%) |
| Jan 2001 | - | -$5.17 M(-304.6%) | -$2.16 M(-150.1%) |
| Oct 2000 | $4.31 M(-216.5%) | $2.52 M(+112.5%) | $4.31 M(+141.2%) |
| Jul 2000 | - | $1.19 M(-268.3%) | $1.78 M(-211.4%) |
| Apr 2000 | - | -$706.00 K(-154.3%) | -$1.60 M(+7.1%) |
| Jan 2000 | - | $1.30 M(>+9900.0%) | -$1.50 M(-59.5%) |
| Oct 1999 | -$3.70 M(+8.7%) | $3000.00(-100.1%) | -$3.70 M(-9.8%) |
| Jul 1999 | - | -$2.20 M(+266.7%) | -$4.10 M(-8.9%) |
| Apr 1999 | - | -$600.00 K(-33.3%) | -$4.50 M(-19.6%) |
| Jan 1999 | - | -$900.00 K(+125.0%) | -$5.60 M(+64.7%) |
| Oct 1998 | -$3.40 M(-38.2%) | -$400.00 K(-84.6%) | -$3.40 M(-26.1%) |
| Jul 1998 | - | -$2.60 M(+52.9%) | -$4.60 M(+39.4%) |
| Apr 1998 | - | -$1.70 M(-230.8%) | -$3.30 M(+13.8%) |
| Jan 1998 | - | $1.30 M(-181.3%) | -$2.90 M(-47.3%) |
| Oct 1997 | -$5.50 M(+52.8%) | -$1.60 M(+23.1%) | -$5.50 M(+41.0%) |
| Jul 1997 | - | -$1.30 M(0.0%) | -$3.90 M(+50.0%) |
| Apr 1997 | - | -$1.30 M(0.0%) | -$2.60 M(+100.0%) |
| Jan 1997 | - | -$1.30 M | -$1.30 M |
| Oct 1996 | -$3.60 M | - | - |
FAQ
- What is Lifecore Biomedical annual cash flow from operations?
- What is the all time high annual CFO for Lifecore Biomedical?
- What is Lifecore Biomedical annual CFO year-on-year change?
- What is Lifecore Biomedical quarterly cash flow from operations?
- What is the all time high quarterly CFO for Lifecore Biomedical?
- What is Lifecore Biomedical quarterly CFO year-on-year change?
- What is Lifecore Biomedical TTM cash flow from operations?
- What is the all time high TTM CFO for Lifecore Biomedical?
- What is Lifecore Biomedical TTM CFO year-on-year change?
What is Lifecore Biomedical annual cash flow from operations?
The current annual CFO of LFCR is -$217.00 K
What is the all time high annual CFO for Lifecore Biomedical?
Lifecore Biomedical all-time high annual cash flow from operations is $29.84 M
What is Lifecore Biomedical annual CFO year-on-year change?
Over the past year, LFCR annual cash flow from operations has changed by +$17.22 M (+98.76%)
What is Lifecore Biomedical quarterly cash flow from operations?
The current quarterly CFO of LFCR is -$6.11 M
What is the all time high quarterly CFO for Lifecore Biomedical?
Lifecore Biomedical all-time high quarterly cash flow from operations is $18.27 M
What is Lifecore Biomedical quarterly CFO year-on-year change?
Over the past year, LFCR quarterly cash flow from operations has changed by $0.00 (0.00%)
What is Lifecore Biomedical TTM cash flow from operations?
The current TTM CFO of LFCR is $71.00 K
What is the all time high TTM CFO for Lifecore Biomedical?
Lifecore Biomedical all-time high TTM cash flow from operations is $37.51 M
What is Lifecore Biomedical TTM CFO year-on-year change?
Over the past year, LFCR TTM cash flow from operations has changed by $0.00 (0.00%)